An alternative explanation that in our settings JNK-1 deficiency in skeletal muscle fails to improve obesity-associated disorders might be the diverging gene targeting strategies used by us and others [17], [19]. The gene discussed is MAPK8; the disease is obesity due to melanocortin 4 receptor deficiency.